Table: CTTI Recommended Strategies for Optimizing Data Quality
Managing Data
CTTI Paper Reveals Investigator Perspectives on Advantages and Challenges of Digital Health Trials
Now more than ever, mobile technology is affecting every aspect of our lives, including the way we conduct clinical research. In a new preprint manuscript, CTTI examines the investigator experience in digital health trials.*
In-depth interviews conducted with 12 investigators representing an array of clinical specialties revealed the benefits and challenges of incorporating mobile technology into clinical trials through the use of smartphones, tablets, notebook computers, and wearable devices.
Some common benefits of digital health trials cited by the investigators include:
- Streamlined study operations and data collection
- Simplified and continuous study data capture throughout the trial
- Improved study and data quality and an increase of “real-world” results
The manuscript also details specific challenges investigators faced when using digital health technologies in trials. These include an increase in the amount of time needed by investigators and study personnel to review data and maintain the technology, additional training, technology adoption barriers for participants and staff, and uncertainty with data validity. These potential obstacles must be proactively addressed in order to harness the full benefits of digital health trials.
Learn more about CTTI’s Digital Health Trials work.
*CTTI’s Digital Health Trials work was previously called “Mobile Clinical Trials”.
Watch Live from FDA’s White Oak Campus: CTTI Unveils Mobile Technologies Recommendations
Are you interested in transforming clinical trials by using mobile technologies for data capture? A clear road map for making this vision a reality is now here.
Watch live as leaders in clinical trials and mobile technologies unveil CTTI’s new Mobile Technologies recommendations from the U.S. Food and Drug Administration’s (FDA) White Oak Campus. Throughout the day, attendees will hear insights and practical guidance for:
- Selecting mobile technologies for data capture that are appropriate to the trial.
- Capturing complete, attributable, and high-quality data.
- Managing the data generated by mobile technologies—including safety considerations, data integrity, and security issues.
- Designing and executing a protocol that uses mobile technologies for data capture.
- Preparing for FDA submission and inspection.
The event will culminate with an engaging panel discussion on the future of mobile technologies in clinical trials. Panelists will include Francesca Cerreta of the European Medicines Agency; Ray Dorsey of the University of Rochester Medical Center; Pat Furlong of Parent Project Muscular Dystrophy; John Hubbard of Genstar Capital; and Leonard Sacks of the FDA.
- Date and Time: Mon., July 16, 2018; 9:30 a.m. – 5:00 p.m.
- View agenda
- When it’s time, Join the Live Stream